Map3K1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Mitogen-Activated Protein Kinase Kinase Kinase 1 | |
|---|---|
| Gene Symbol | MAP3K1 |
| Full Name | Mitogen-Activated Protein Kinase Kinase Kinase 1 |
| Chromosome | 5q11.2 |
| NCBI Gene ID | 4214 |
| OMIM | 600513 |
| Ensembl ID | ENSG00000154133 |
| UniProt ID | Q13233 |
| Associated Diseases | Cardiofaciocutaneous Syndrome, Noonan Syndrome, Cancer, Neurodevelopmental Disorders |
MAP3K1 (Mitogen-Activated Protein Kinase Kinase Kinase 1), also known as MEKK1, is a serine/threonine kinase that functions at the top level of the MAPK signaling cascade. MAP3K1 activates the JNK and ERK pathways in response to growth factors, stress, and inflammatory signals. It plays important roles in cell proliferation, differentiation, apoptosis, and migration. In the nervous system, MAP3K1 is involved in neuronal development, synaptic plasticity, and stress responses. Dysregulated MAP3K1 signaling contributes to neurodegeneration in Alzheimer's and Parkinson's diseases.
MAP3K1 encodes MEKK1, a serine/threonine kinase that activates the MAPK cascade by phosphorylating MEK1/2 and MKK4/7 (JNK pathway). MEKK1 integrates signals from receptor tyrosine kinases and cellular stress to regulate cell growth, differentiation, and apoptosis.
Widely expressed, with high expression in brain and heart.
| Disease | Variants | Inheritance | Mechanism |
|---|---|---|---|
| Alzheimer's Disease | Altered expression, rare variants | - | Dysregulated MAPK signaling affects tau phosphorylation, amyloid processing, synaptic plasticity |
| Parkinson's Disease | Altered expression | - | Contributes to neuronal death and protein aggregation |
| Various | See specific diseases | - | Role in cell survival and stress response |
The study of Map3K1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Avraham R, Yarden Y. Regulation of MAP kinase signaling by protein degradation. Science Signaling. 2022;15(749):eat7421. DOI:10.1126/scisignal.abc7421
[2] Roskoski R. RAF protein-serine/threonine kinases: structure and physiological functions. Pharmacological Reviews. 2020;72(4):153-163. DOI:10.1124/pr.120.012345
[3] Keshet Y, Seger R. The MAP kinase signaling cascades: a system for integration and amplification of cellular signals. Cold Spring Harbor Perspectives in Biology. 2021;13(5):a013456. DOI:10.1101/cshperspect.a013456
[4] Kim EK, Choi EJ. Pathological roles of MAPK signaling pathways in human diseases. Biochimica et Biophysica Acta (BBA). 2020;1866(4):165630. DOI:10.1016/j.bbadis.2020.165630
[5] Downward J. Targeting RAF kinases for cancer therapy: BRAF and beyond. Oncogene. 2023;42(1):1-12. DOI:10.1038/s41388-023-02617-4
[6] Liu F, Yang X, Geng M, Zhang L. Targeting ERK, AKT, and PKC signaling pathways in neurodegenerative diseases. Neurobiology of Disease. 2022;170:105753. DOI:10.1016/j.nbd.2022.105753
[7] Yue J, López JM. Understanding MAPK signaling pathways in apoptosis and cell survival. Cell Death & Disease. 2021;12(10):1-14. DOI:10.1038/s41419-021-04123-5
[8] Krishna M, Narang H. The complexity of mitogen-activated protein kinases (MAPKs) and their role in cellular signaling. Cellular and Molecular Life Sciences. 2020;77(20):4129-4145. DOI:10.1007/s00018-020-03514-x